P003 Innovation in Dermatologic Surgery
DESCRIPTION
The purpose of this session is to introduce the audience to advances in dermatologic surgery. The session will include the use of artificial intelligence in running a surgical dermatology practice and other innovative practice management concepts. It will also discuss innovation in the diagnosis and treatment of skin cancer, advances in the aesthetics industry, and how to utilize innovation to deliver personalized care.
LEARNING OBJECTIVES
Identify novel technologies which improve the practice of dermatologic surgery.
Incorporate new diagnostic techniques into your practice
Determine which advances should be used to deliver individualized surgical dermatology care.
SCHEDULE
10:00 AM
Introduction
Martha Laurin Council, MD, MA, MBA, FAAD
11:55 AM
Concluding Remarks
Martha Laurin Council, MD, MA, MBA, FAAD
DIRECTOR
Martha Laurin Council, MD, MA, MBA, FAAD
Washington University in St. Louis
SPEAKERS
Lilia M. Correa, MD, FAAD
USF / Moffitt Cancer Center
Rachel L. Kyllo, MD, FAAD
Meramec Dermatology, LLC
Aubriana McEvoy, MS, MD, FAAD
Washington University, St. Louis
Daniel Isaac Schlessinger, MD, FAAD
Schlessinger MD; Volunteer Faculty, University of Nebraska Medical Center
Stanislav Nickolaevich Tolkachjov, MD, FAAD
Professor/Texas A&M School of Medicine; Fellowship Director & Core Faculty; Baylor University Medical Center; Director of Mohs/Epiphany Dermatology; Clinical Assistant Professor/UT Southwestern Medical Center
DISCLOSURES
Lilia M. Correa, MD, FAAD
AccuTec Blades – Consultant(Honoraria); Enspectra Health – Consultant (1099 relationship)(Honoraria); La Roche Posay Dermatologique – Speaker(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Patient Point – Advisory Board(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals Inc – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding);
Martha Laurin Council, MD, MA, MBA, FAAD
Castle Biosciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Rachel L. Kyllo, MD, FAAD
No financial relationships exist with ineligible companies.
Aubriana McEvoy, MS, MD, FAAD
No financial relationships exist with ineligible companies.
Daniel Isaac Schlessinger, MD, FAAD
AbbVie – Investigator(Fees); Almirall – Investigator(Fees); Alumis – Investigator(Fees); Apollo Therapeutics Ltd – Investigator(Fees); Appiell Inc. – Consultant(Stock); Caliway Biopharmaceuticals Co., Ltd – Investigator(Fees); Celldex – Investigator(Fees); FixMySkin – Founder(Patent royalties or other compensation for Intellectual Property Rights); Incyte Corporation – Investigator(Fees); Ipsen – Investigator(Fees); K-Health – Stockholder(No Compensation Received); LovelySkin – Employee (w-2 relationship)(Salary); LuminDx – Consultant(No Compensation Received); MoonLake Immunotherapeutics – Investigator(Fees); Nielsen BioSciences – Advisory Board(Stock), Investigator(Fees); Novartis – Investigator(Fees); Oruka Therapeutics – Investigator(Fees); Pfizer Inc. – Investigator(Fees); ProTransit Nanotherapy – Advisory Board(Stock), Investigator(Fees); Sanofi – Investigator(Fees); Sun Pharmaceutical Industries Ltd. – Investigator(Fees); Takeda Pharmaceuticals USA Inc – Investigator(Fees); UCB – Investigator(Fees); VeraDermics Inc. – Advisory Board(Honoraria); Verrica Pharmaceuticals Inc. – Investigator(Fees);
Stanislav Nickolaevich Tolkachjov, MD, FAAD
Boehringer Ingelheim – Speaker(Honoraria); Castle Biosciences – Speaker(Honoraria); Kerecis Limited – Speaker(Grants/Research Funding); Leo Pharma – Speaker(Honoraria); StimLabs – Investigator(Grants/Research Funding);